[Monoclonal gammapathy of indeterminate origin and myeloma]

Rev Med Liege. 1988 Apr 15;43(8):270-4.
[Article in French]
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation
  • Carmustine / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Diagnosis, Differential
  • Doxorubicin / therapeutic use
  • Drug Therapy, Combination
  • Humans
  • Hypergammaglobulinemia* / diagnosis
  • Hypergammaglobulinemia* / etiology
  • Interferon Type I / therapeutic use
  • Melphalan / administration & dosage
  • Melphalan / therapeutic use
  • Methylprednisolone / administration & dosage
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Monoclonal Gammopathy of Undetermined Significance* / etiology
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / therapy
  • Prednisone / therapeutic use
  • Vincristine / therapeutic use

Substances

  • Interferon Type I
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Melphalan
  • Carmustine
  • Prednisone
  • Methylprednisolone

Supplementary concepts

  • VBAP protocol
  • VMCP protocol